AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 104 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $666,000 | +27.3% | 70,872 | +3.7% | 0.00% | 0.0% |
Q2 2020 | $523,000 | +23.3% | 68,372 | -0.3% | 0.00% | 0.0% |
Q1 2020 | $424,000 | -52.5% | 68,600 | -6.4% | 0.00% | 0.0% |
Q4 2019 | $892,000 | -3.9% | 73,300 | -8.7% | 0.00% | 0.0% |
Q3 2019 | $928,000 | +29.2% | 80,327 | +11.8% | 0.00% | 0.0% |
Q2 2019 | $718,000 | -32.5% | 71,853 | -13.0% | 0.00% | 0.0% |
Q1 2019 | $1,064,000 | -19.5% | 82,584 | -5.1% | 0.00% | -50.0% |
Q4 2018 | $1,321,000 | -23.5% | 86,987 | +0.8% | 0.00% | 0.0% |
Q3 2018 | $1,726,000 | -1.9% | 86,297 | -4.4% | 0.00% | 0.0% |
Q2 2018 | $1,760,000 | -9.3% | 90,252 | -6.3% | 0.00% | -33.3% |
Q1 2018 | $1,941,000 | +73.9% | 96,339 | +14.4% | 0.00% | +50.0% |
Q4 2017 | $1,116,000 | -28.2% | 84,241 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $1,554,000 | +2.0% | 84,241 | +1.7% | 0.00% | 0.0% |
Q2 2017 | $1,524,000 | -16.6% | 82,800 | +2.2% | 0.00% | -33.3% |
Q1 2017 | $1,827,000 | -37.9% | 81,000 | -4.1% | 0.00% | -40.0% |
Q4 2016 | $2,941,000 | +35.1% | 84,500 | -4.8% | 0.01% | +25.0% |
Q3 2016 | $2,177,000 | -4.3% | 88,800 | -6.6% | 0.00% | 0.0% |
Q2 2016 | $2,275,000 | -0.9% | 95,100 | -3.1% | 0.00% | 0.0% |
Q1 2016 | $2,296,000 | -26.9% | 98,100 | -5.7% | 0.00% | -20.0% |
Q4 2015 | $3,140,000 | -47.7% | 104,000 | -31.1% | 0.01% | -50.0% |
Q3 2015 | $5,999,000 | -41.0% | 151,000 | +2.6% | 0.01% | -33.3% |
Q2 2015 | $10,166,000 | +109.4% | 147,200 | +34.4% | 0.02% | +114.3% |
Q1 2015 | $4,855,000 | 0.0% | 109,500 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $4,855,000 | +92.6% | 109,500 | +38.6% | 0.01% | +133.3% |
Q3 2014 | $2,521,000 | +54.0% | 79,000 | 0.0% | 0.00% | +50.0% |
Q2 2014 | $1,637,000 | +15.1% | 79,000 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $1,422,000 | -24.8% | 79,000 | 0.0% | 0.00% | -33.3% |
Q4 2013 | $1,890,000 | +10.1% | 79,000 | -1.2% | 0.00% | 0.0% |
Q3 2013 | $1,717,000 | -10.0% | 79,954 | -6.8% | 0.00% | -25.0% |
Q2 2013 | $1,908,000 | – | 85,754 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |